JP2016505538A5 - - Google Patents

Download PDF

Info

Publication number
JP2016505538A5
JP2016505538A5 JP2015544208A JP2015544208A JP2016505538A5 JP 2016505538 A5 JP2016505538 A5 JP 2016505538A5 JP 2015544208 A JP2015544208 A JP 2015544208A JP 2015544208 A JP2015544208 A JP 2015544208A JP 2016505538 A5 JP2016505538 A5 JP 2016505538A5
Authority
JP
Japan
Prior art keywords
seq
residues
influenza
polypeptide
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015544208A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016505538A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/072279 external-priority patent/WO2014085616A1/en
Publication of JP2016505538A publication Critical patent/JP2016505538A/ja
Publication of JP2016505538A5 publication Critical patent/JP2016505538A5/ja
Pending legal-status Critical Current

Links

JP2015544208A 2012-11-27 2013-11-27 H1n1インフルエンザに対する計算で最適化した広い反応性を示す抗原 Pending JP2016505538A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261730186P 2012-11-27 2012-11-27
US61/730,186 2012-11-27
PCT/US2013/072279 WO2014085616A1 (en) 2012-11-27 2013-11-27 Computationally optimized broadly reactive antigens for h1n1 influenza

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018124432A Division JP2018183149A (ja) 2012-11-27 2018-06-29 H1n1インフルエンザに対する計算で最適化した広い反応性を示す抗原

Publications (2)

Publication Number Publication Date
JP2016505538A JP2016505538A (ja) 2016-02-25
JP2016505538A5 true JP2016505538A5 (enExample) 2016-11-24

Family

ID=50773495

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015544208A Pending JP2016505538A (ja) 2012-11-27 2013-11-27 H1n1インフルエンザに対する計算で最適化した広い反応性を示す抗原
JP2018124432A Withdrawn JP2018183149A (ja) 2012-11-27 2018-06-29 H1n1インフルエンザに対する計算で最適化した広い反応性を示す抗原

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018124432A Withdrawn JP2018183149A (ja) 2012-11-27 2018-06-29 H1n1インフルエンザに対する計算で最適化した広い反応性を示す抗原

Country Status (13)

Country Link
US (3) US9309290B2 (enExample)
EP (1) EP2925773B1 (enExample)
JP (2) JP2016505538A (enExample)
KR (1) KR20150089005A (enExample)
CN (1) CN104797594A (enExample)
AU (2) AU2013352179B2 (enExample)
CA (1) CA2891682A1 (enExample)
HK (1) HK1212708A1 (enExample)
IN (1) IN2015DN03070A (enExample)
MX (1) MX2015005056A (enExample)
RU (1) RU2015124805A (enExample)
SG (1) SG11201503989PA (enExample)
WO (1) WO2014085616A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883171B2 (en) * 2010-09-14 2014-11-11 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for influenza
EP2721158B1 (en) * 2011-06-20 2017-05-03 University of Pittsburgh - Of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for h1n1 influenza
IN2014DN07399A (enExample) 2012-03-30 2015-04-24 Univ Pittsburgh
WO2016100922A1 (en) * 2014-12-19 2016-06-23 Oregon Health & Science University Synergistic co-administration of computationally optimized broadly reactive antigens for h1n1 influenza
CN108290932A (zh) 2015-06-09 2018-07-17 圣诺菲·帕斯图尔公司 优化编码工程改造的流感蛋白的核苷酸序列的方法
US11116832B2 (en) 2016-06-03 2021-09-14 Sanofi Pasteur Inc. Modification of engineered influenza hemagglutinin polypeptides

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE376059T1 (de) 2000-06-23 2007-11-15 Wyeth Corp Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps)
US20050181459A1 (en) 2002-06-11 2005-08-18 Matthew Baker Method for mapping and eliminating T cell epitopes
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
EP1851238A4 (en) 2005-02-24 2008-12-31 Univ Massachusetts FLUID NUCLEIC ACIDS, POLYPEPTIDES AND USES THEREOF
WO2007011904A2 (en) 2005-07-19 2007-01-25 Dow Global Technologies Inc. Recombinant flu vaccines
WO2007072214A2 (en) 2005-12-19 2007-06-28 Novartis Vaccines And Diagnostics Srl Methods of clustering gene and protein sequences
US20080045472A1 (en) 2006-03-31 2008-02-21 Council Of Scientific And Industrial Research Bharat Biotech Targets for human micro rnas in avian influenza virus (h5n1) genome
HRP20130163T1 (hr) 2006-09-07 2013-03-31 Crucell Holland B.V. Ljudske molekule za vezanje koje mogu neutralizirati virus influence h5n1 i njihova uporaba
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
AU2008331673B2 (en) * 2007-11-12 2014-12-11 The Trustees Of The University Of Pennsylvania Novel vaccines against multiple subtypes of influenza virus
SG187500A1 (en) * 2008-01-21 2013-02-28 Medicago Inc Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
US7981428B2 (en) 2008-01-23 2011-07-19 Academia Sinica Flu vaccines and methods of use thereof
WO2010036970A2 (en) 2008-09-25 2010-04-01 Fraunhofer Usa, Inc. Influenza vaccines, antigens, compositions, and methods
WO2010036948A2 (en) 2008-09-26 2010-04-01 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Dna prime/inactivated vaccine boost immunization to influenza virus
KR101715418B1 (ko) 2009-04-03 2017-03-10 메리얼 인코포레이티드 뉴캐슬 질환 바이러스-벡터를 이용한 조류 백신
HRP20180706T1 (hr) * 2009-06-24 2018-06-01 Medicago Inc. Kimerna gripa nalik čestici koja sadrži hemaglutinin
US20110184160A1 (en) * 2010-01-26 2011-07-28 Weiner David B Nucleic acid molecule encoding consensus influenza a hemagglutinin h1
US8298820B2 (en) 2010-01-26 2012-10-30 The Trustees Of The University Of Pennsylvania Influenza nucleic acid molecules and vaccines made therefrom
CN102373184A (zh) * 2010-08-09 2012-03-14 中山大学 禽流感和传染性支气管炎混合病毒样颗粒、制备方法和应用
US8883171B2 (en) * 2010-09-14 2014-11-11 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for influenza
EP2721158B1 (en) * 2011-06-20 2017-05-03 University of Pittsburgh - Of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for h1n1 influenza
AU2013217166B2 (en) 2012-02-07 2017-04-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Computationally optimized broadly reactive antigens for H3N2, H2N2, and B influenza viruses
US9566327B2 (en) 2012-02-13 2017-02-14 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for human and avian H5N1 influenza
IN2014DN07399A (enExample) * 2012-03-30 2015-04-24 Univ Pittsburgh

Similar Documents

Publication Publication Date Title
JP2015506705A5 (enExample)
RU2014101401A (ru) Антигены вируса гриппа h1n1 с широким спектром активности, оптимизированные с применением вычислительных средств
RU2018113521A (ru) Рекомбинантный полипептид гемагглютинин (ha) вируса гриппа для вызова иммунного ответа в отношении вирусов гриппа h2n2 или b
RU2017141447A (ru) Рекомбинантные полипептиды гемагглютинина (ha) вируса гриппа, композиции, содержащие их, и способы вызова иммунного ответа в отношении вируса гриппа h1n1
JP6957580B2 (ja) 新規多価ナノ粒子に基づくワクチン
JP2016505538A5 (enExample)
JP2014502156A5 (enExample)
RU2019139064A (ru) Композиции и способы для лечения цитомегаловируса
Valkenburg et al. Immunity to seasonal and pandemic influenza A viruses
RU2017113571A (ru) Рекомбинантные вакцины от fmdv и их применение
JP2014530010A5 (enExample)
HRP20171213T1 (hr) Glikoproteinske čestice nalik virusu (vlp) bjesnoće
JP2017503482A5 (enExample)
JP2015505299A5 (enExample)
JP2015119730A5 (enExample)
JP2012095652A5 (enExample)
JP2009544318A5 (enExample)
JP2013216685A5 (enExample)
RU2015124805A (ru) Оптимизированные с помощью вычислительных средств антигены с широким спектром реактивности для вируса гриппа h1n1
JP2015501840A5 (enExample)
JP2014519817A5 (enExample)
JP2010535026A5 (enExample)
JP2015524422A5 (enExample)
JP2013517773A5 (enExample)
JP2009540801A5 (enExample)